BioSpace News Archive

Emerging health threats, uncured diseases and the need to deliver critical therapies to patients are driving biotech companies to search for ways to build flexibility into their complex product pipelines and deliver projects in record time.

Allergan Aesthetics, an AbbVie company, announced the launch of SkinMedica® TNS® Advanced+ Pro-Infusion Serum for DiamondGlow™ treatments.

Vexos Inc., a Global Electronics Manufacturing Services provider, is pleased to announce that Health Canada has approved the Mechanical Ventilator Milano (MVM) ventilator for use under Interim Order. In May, Vexos signed a contract with the Government of Canada to manufacture and supply 10,000 MVM units as part of the national mobi

I-Mab (the “Company”) (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today

October is Breast Cancer Awareness Month and The American Cancer Society is urging women to talk to their doctors to find out what’s best for them

Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, and US Oncology Research, one of the largest community-based oncology site management organizations in the U.S., announced today a collaboration to utilize the US Oncology Research Selected Trials for Accelerated Rollout (STAR) program for patient enrollment in the registration-enabling Phase 2 CRESTONE study

Shatterproof’s National Movement to End Stigma and online Addiction Treatment Needs Assessment Tool offer resources dedicated to better addressing the needs of those struggling with addiction

Lead program FL-101, an IL-1β neutralizing antibody, expected to enter clinical testing in 1H-2021 in patients with non-small cell lung cancer Kris Jenner, Managing Member at Rock Springs Capital, to join Flame’s Board of Directors [30-September-2020] NEW YORK , Sept. 30, 2020 /PRNewswire/ -- Flame Biosciences, a clinical-stage biopharmaceutical company focu

- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced the promotion of John Bencich to Chief Executive Officer. Mr. Bencich has been serving as Achieve’s Chief Financial a

Susan G. Komen®, the world’s leading breast cancer organization, recognized two widely respected and innovative breast cancer researchers this week, announcing that Donald McDonnell, Ph.D., and Laura Esserman, M.D., have been selected as this year’s recipients of the Brinker Awards – Komen’s highest scientific honor. Establish